US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...

“Although not named in this case, all drug manufacturers should be ... adding that the company has not raised list prices for ...

The lawsuits generally make two claims: that insulin prices are unreasonably ... placement for a medicine on the formulary, or list of covered drugs, that they control. If a drug maker doesn ...

For drugs like insulin, which require delivery devices ... According to an agency press release, the list of patents that the FTC flagged as potentially improper include those for various inhalers ...

Novo Nordisk reported one counterfeit pen contained the diabetes medicine insulin. The user was hospitalized ... allows users to verify if a website selling medications has been vetted. You can also ...

For example, two plans of one insurer list four insulins in ... changes in the coverage of these drugs, which becomes an important concern for those who need insulin. There are probably 12 or ...

This system also means that insurers end up with different rates for each drug company, so a brand of insulin that has a minimal co-pay under one insurance could cost the full list price under ...

Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...

which are negotiated with drug manufacturers and are tied to a drug’s list price. Insulin products with higher list prices result in higher rebates and fees for the PBMs, the complaint alleges.

Doescher: I just want to make sure I get that. Haislmaier: The drug, the list price goes up. Doescher: Yes. The price for my insulin goes up. Haislmaier: And you may be paying more as the patient ...

Many patients pay for insulin based on a percentage of the drug’s list price, not the discounted price. The higher the list price, the more unaffordable the drug becomes, regardless of the discount ...

Tirzepatide, known under the brand name Mounjaro is prescribed for type 2 diabetes, but has been shown in clinical trials to ...